GRAIL, Inc. GRAL
139.44 USD +5.68 (+4.25%)
At closeNov 3, 2026, 4:00 PM EST
139.44 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
136.66 Day range 144.04
41.50 52-week range 166.48
- YTD
- +62.92%
- 1 year
- +55.26%
Analyst view
Consensus: buy
Buy
Price target (mean) 132.56 -4.9% downside
Now 139.44
- Target (low)
- 74.00
- Target (mean)
- 132.56
- Target (high)
- 180.00
Ratings (0m) 10 5 buy · 5 hold · 0 sell
- Strong buy0
- Buy5
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 11
- 2 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.90 | -2.85 – -1.49 | -2.46 | +22.8% | 44.21M | +22.1% | 4 |
| Next quarter | -2.09 | -2.82 – -1.51 | -2.44 | +14.4% | 51.16M | +17.3% | 5 |
| Current year | -7.52 | -10.37 – -5.93 | -11.69 | +35.7% | 180.80M | +22.9% | 5 |
| Next year | -8.25 | -10.72 – -6.32 | -7.52 | -9.8% | 227.21M | +25.7% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 13, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 2, 2026 | UBS | Maintained | Buy | Buy |
| Oct 1, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 28, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 25, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Sep 22, 2026 | Baird | Maintained | Outperform | Outperform |
| Sep 17, 2026 | RBC Capital | Initiated | — | Sector Perform |
| Sep 9, 2026 | UBS | Initiated | — | Buy |
| Jul 15, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Jun 5, 2026 | Goldman Sachs | Initiated | — | Neutral |
| May 6, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 6, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Apr 10, 2026 | Mizuho | Initiated | — | Neutral |
| Apr 10, 2026 | Piper Sandler | Initiated | — | Neutral |
| Mar 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Feb 24, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Feb 20, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Feb 20, 2026 | Baird | Maintained | Outperform | Outperform |
| Feb 17, 2026 | Baird | Initiated | — | Outperform |
| Jan 26, 2026 | Guggenheim | Maintained | Buy | Buy |
| Dec 2, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 17, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 12, 2025 | Guggenheim | Upgrade | Neutral | Buy |
| Oct 22, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 3, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| May 14, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Apr 21, 2025 | Canaccord Genuity | Initiated | — | Buy |
| Mar 18, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Nov 27, 2024 | Morgan Stanley | Initiated | — | Equal-Weight |